Paediatric AML: 9 Key Facts on Treatment & Care

Childhood acute myeloid leukemia (AML) is a rare cancer in kids, mostly in babies and teens. It makes up about 20% of all leukemia in children. At Liv Hospital, we are committed to delivering world-class healthcare with full support for international patients.

Getting a diagnosis of AML can change a family’s life. But, thanks to new genetic tests and treatments, there’s hope. Our team works hard to use the newest ways to diagnose and treat AML. This helps kids live better and longer with this disease.

Key Takeaways

• Paediatric AML is a rare and complex form of childhood cancer.
• It requires prompt and specialized care to improve survival rates.
• Genetic profiling and risk-adapted therapies are key for effective treatment.
• Liv Hospital offers full support for international patients.
• Our team is dedicated to delivering top-notch healthcare for children with AML.
• Advances in diagnosis and treatment are making life better for kids with Paediatric AML.

What is Paediatric AML?

Paediatric AML, or Acute Myeloid Leukemia, is a cancer that affects kids’ blood and bone marrow. It’s caused by the growth of immature white blood cells. These cells are important for fighting off infections.

We will look at how Paediatric AML is different from adult AML.

Definition and Classification of Acute Myeloid Leukemia

AML is a cancer that starts in the bone marrow. It happens when a stem cell turns bad and grows out of control. This leads to too many immature cells in the blood and bone marrow.

There are two main ways to classify AML. The French-American-British (FAB) and the World Health Organization (WHO) systems are used.

How Childhood AML Differs from Adult AML

Childhood AML is different from adult AML in many ways. For example, some genetic changes are more common in kids. These changes can affect how the disease is treated.

“The genetic landscape of Paediatric AML is distinct, with certain chromosomal abnormalities being more common in children than in adults, impacting treatment strategies and outcomes.”

Paediatric AML also responds differently to treatment. This means kids often need special treatment plans.

Understanding these differences helps doctors create better treatment plans for kids with AML.

Epidemiology and Risk Factors

The study of Paediatric AML gives us important information. It tells us about how common it is, who gets it, and why. Knowing this helps doctors find better ways to diagnose and treat it.

Incidence Rates in Children

Paediatric AML makes up about 20% of all leukemia in kids. It happens to about 4.8 kids per 100,000 each year. This shows we need to keep looking into why it happens.

Age Distribution: Infancy and Adolescence Peaks

Paediatric AML is more common in babies and teenagers. This tells us that different things might cause it at different ages. Studying this can help us understand why it happens and how to stop it.

Known Risk Factors for Developing Childhood AML

There are known risks for Paediatric AML, like genes and the environment. Kids with Down syndrome are more likely to get it. Also, some chemicals and radiation can increase the risk. Knowing these risks helps doctors catch it early and prevent it.

We know Paediatric AML is a complex issue. It’s influenced by genes, the environment, and possibly more. We need to keep researching to help kids with AML.

Recognizing Symptoms of Childhood AML

Parents need to know the common signs of Paediatric AML to get help quickly. Acute Myeloid Leukemia in kids shows different signs. These signs are not just for AML but need a doctor’s check if they last or are bad.

Early Warning Signs Parents Should Know

The first signs of Paediatric AML can look like common sicknesses or other kid’s illnesses. Fatigue, weakness, and shortness of breath are early signs. They happen because of fewer red blood cells.

Getting sick often is another sign. Kids with AML might get fevers, sore throats, or infections that don’t get better.

Physical Manifestations

Physical signs of Paediatric AML include bruising and bleeding. This is because of low platelet counts. Easy bruising, nosebleeds, or bleeding gums are big worries.

Petechiae, small spots on the skin from tiny bleeds, are also a sign. A big liver or spleen and swollen lymph nodes can be found during a check-up.

Systemic Symptoms and Behavioral Changes

Systemic symptoms include weight loss, loss of appetite, and bone or joint pain. These can really hurt a child’s health and happiness.

Behavioral changes like being irritable or tired are also signs. It’s key for parents to watch their child’s mood and health. If they see anything odd or lasting, they should see a doctor.

Spotting these symptoms early can really help with treating Paediatric AML. If you think your child has any of these signs, seeing a doctor right away is very important.

The Diagnostic Process for Paediatric AML

Diagnosing Paediatric AML involves several steps. First, a doctor assesses the patient’s medical history and performs a physical exam. Then, blood tests and specialized tests are done to understand the leukemia’s characteristics. Accurate diagnosis is key to creating a good treatment plan.

Initial Assessment and Blood Work

The first step is an initial assessment. This includes a detailed medical history and physical exam. Blood tests are a big part of this step.

• Complete Blood Count (CBC): This test checks the levels of blood cells. It looks for abnormal counts that might show leukemia.
• Blood Smear: A blood smear test finds abnormal cells. These cells, like blasts, can be signs of leukemia.

Bone Marrow Examination Procedures

A bone marrow test is vital for diagnosing Paediatric AML. It involves two main steps:

1. Bone Marrow Aspiration: This step removes bone marrow fluid with a needle. The fluid is checked for abnormal cells.
2. Bone Marrow Biopsy: A biopsy takes a small bone tissue sample. It’s examined for leukemia cells.

Advanced Diagnostic Techniques and Classification

After confirming AML, advanced tests are used to classify it. These include:

• Genetic Testing: Tests like FISH and molecular testing find genetic issues in AML.
• Immunophenotyping: This method analyzes leukemia cell proteins. It helps understand their origin and characteristics.

Getting a precise diagnosis and classification of Paediatric AML is vital. It helps choose the best treatment and improves patient results.

Genetic and Molecular Characteristics

Understanding Paediatric AML’s genetic and molecular traits is key to better treatments. Paediatric AML is diverse, and its genes greatly influence its course and treatment success.

Common Genetic Abnormalities in Childhood AML

Paediatric AML has many genetic issues, like chromosomal changes and mutations. These can change how the disease acts and how it responds to treatment.

Some common genetic problems in Paediatric AML include:

• Chromosomal Translocations: These are when chromosomes swap parts, creating new genes that can cause leukemia.
• Mutations: Certain gene changes, like in FLT3, NPM1, and WT1, are often seen in Paediatric AML. They can affect how well the disease does.

How Genetic Profiling Influences Treatment Decisions

Genetic testing is now a big part of treating Paediatric AML. It helps doctors create treatments that fit each patient’s needs.

Using genetic testing in treatment has made it better for kids with Paediatric AML. It helps doctors plan treatments that are just right for each child. Research keeps finding new ways to target Paediatric AML, giving hope for even better treatments.

Comprehensive Treatment Approaches

Treating Paediatric Acute Myeloid Leukemia (AML) requires a mix of treatments. We use different strategies to help each child recover. This approach gives them the best chance of beating the disease.

Chemotherapy Protocols

Chemotherapy is key in treating Paediatric AML. It includes strong treatments to get the leukemia under control. These treatments help the child get better and stay that way.

Chemotherapy for Paediatric AML is complex. It includes:

• Intensive induction chemotherapy to achieve remission
• Consolidation chemotherapy to eliminate any remaining leukemia cells
• Central nervous system (CNS) prophylaxis to prevent CNS involvement

Targeted Therapies and Emerging Treatments

Targeted therapies and new treatments are also important. They aim to attack specific problems in the disease. This helps in managing Paediatric AML better.

Some of these treatments include:

• FLT3 inhibitors for patients with FLT3 mutations
• Other molecularly targeted agents under investigation in clinical trials

Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation (HSCT) is a big part of treating AML in kids. It’s very important for those with high-risk disease or who have relapsed.

HSCT’s role in Paediatric AML is:

1. Providing a potentially curative option for high-risk patients
2. Consolidating remission in patients with relapsed or refractory disease

We look at each patient’s situation to decide if HSCT is right for them. We consider disease risk, donor availability, and the patient’s health.

Multidisciplinary Care for Children with AML

Treating Paediatric AML needs a team of experts. It’s not just about medicine. It’s about caring for the whole child and their family.

Pediatric Oncologists: Leading the Care Team

Pediatric oncologists are key in the team. They plan and lead the treatment. They work with others to give the best care for each child.

The role of pediatric oncologists includes:

• Developing and implementing treatment plans
• Coordinating care with other specialists
• Monitoring the child’s response to treatment
• Adjusting treatment plans as necessary

Supportive Care Team Members

Supportive care is vital. It helps manage symptoms and improve life quality. The team includes nurses, social workers, and nutritionists.

Psychological Support for Patients and Families

Psychological support is key for families facing AML. We offer help from psychologists and counselors. They support families through tough times.

The benefits of psychological support include:

• Reducing anxiety and stress
• Improving coping mechanisms
• Enhancing family dynamics
• Supporting the child’s emotional well-being

Our multidisciplinary care helps children with AML. They get the support they need to face their treatment journey.

Long-term Outcomes and Survivorship

Children with Paediatric AML now have better chances of survival. This is due to new genetic tests and treatments. As we learn more, we see big improvements in their long-term health.

Prognostic Factors Affecting Survival

Several factors affect how long children with AML live. Genetic abnormalities are very important. Some changes in genes can greatly change treatment results.

How well a child responds to treatment also matters a lot. Molecular profiling helps doctors choose the best treatment for each child. This can improve their survival chances.

The age at diagnosis is also key. Young children and infants face special challenges. Teenagers might have different risks than younger kids. Knowing these differences helps doctors plan better treatments.

Recent Improvements in Survival Rates

Survival rates for children with AML have gone up in recent years. This is thanks to risk-adapted therapies. Treatments are now more focused on each child’s risk level. This makes treatments more effective and safer.

Improvements in supportive care have also helped. Better care for side effects means more kids can finish their treatment. This has greatly improved survival rates.

Long-term Health Monitoring for Survivors

Now, we focus on helping survivors of Paediatric AML stay healthy. Long-term follow-up care is key. It helps catch and manage late effects of treatment.

Research on late effects of AML treatment is ongoing. We aim to find ways to reduce these effects. This includes studying how different treatments affect long-term health.

Conclusion: Advances and Future Directions in Paediatric AML Care

Paediatric Acute Myeloid Leukemia (AML) is a tough disease that needs special care. At Liv Hospital, we aim to give top-notch healthcare to international patients. We use the latest in genetic testing and tailored treatments to help kids with AML live better.

The outlook for AML care in kids is bright, thanks to new research. We’re working towards a future where every child gets the best care. Our team of experts works together to give each patient a treatment plan that fits them.

We’re excited for the future of AML care in kids. New discoveries in genetic testing and treatments will keep improving care. We’re all in this together, committed to making life better for kids with AML.

FAQ

Reference

• National Cancer Institute: Childhood Acute Myeloid Leukemia Treatment (PDQ)

https://www.cancer.gov/types/leukemia/patient/child-aml-treatment-pdq